Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Silk Road Medical Inc.

A novel hybrid carotid artery stenting procedure

This article was originally published in Start Up

Executive Summary

Patients with carotid artery disease currently have two treatment options: traditional surgical repair or transfemoral stenting, but a new minimally invasive therapy that combines the benefits and minimizes the shortcomings of these two choices will soon be available. The ENROUTE procedure from Silk Road Medical Inc. consists of a neuroprotection system that reverses blood flow out of the brain to protect the brain from any debris that is liberated during the procedure, and a permanent stent that props open the narrowed carotid artery.



Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts